Suchergebnisse - "Uchino, Junji"

PubPharm (16)

1

Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases : A Multicenter, Open-Label Single-Arm Phase II Trial

enthalten in: The oncologist | 2023

von Tanimura, K. | Uchino, J. | Kimura, H. | +11

2

A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients : The SPIRAL-0 Study

enthalten in: The oncologist | 2022

von Chihara, Y. | Takeda, T. | Goto, Y. | +20

ErratumIn: Oncologist. 2024 Mar 18;:. - PMID 38498842

3

Editorial : Treatment for Non-Small Cell Lung Cancer in Distinct Patient Populations

enthalten in: Frontiers in oncology | 2022

von Uchino, J. | Goldmann, T. | Kimura, H.

4

The Impact of VEGF Inhibition on Clinical Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy : A Retrospective Cohort Study

enthalten in: Frontiers in oncology | 2021

von Tanimura, K. | Yamada, T. | Omura, A. | +12

5

Serum immune modulators during the first cycle of anti-PD-1 antibody therapy in non-small cell lung cancer : Perforin as a biomarker

enthalten in: Thoracic cancer | 2020

von Ota, T. | Fukui, T. | Nakahara, Y. | +7

6

Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment

enthalten in: Journal of clinical medicine | 2020

von Nakao, A. | Hiranuma, O. | Uchino, J. | +26

7

Rationale and design of a phase II trial of durvalumab treatment in patients with NSCLC ineligible for stage III chemoradiotherapy following radiation monotherapy (SPIRAL-RT study)

enthalten in: Therapeutic advances in medical oncology | 2020

von Yamada, T. | Uchino, J. | Chihara, Y. | +6

8

Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer

enthalten in: Journal of clinical medicine | 2019

von Katayama, Y. | Shimamoto, T. | Yamada, T. | +9

9

Phase I/II Study of Docetaxel and S-1 in Previously-Treated Patients with Advanced Non-Small Cell Lung Cancer : LOGIK0408

enthalten in: Journal of clinical medicine | 2019

von Takayama, K. | Uchino, J. | Fujita, M. | +9

10

Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR-mutated non-small cell lung cancer

enthalten in: Cancer medicine | 2019

von Yamada, T. | Hirai, S. | Katayama, Y. | +14